Related Experiment Videos
COX-2 expression and cell cycle progression in human fibroblasts.
D W Gilroy1, M A Saunders, K K Wu
1Vascular Biology Research Center and Division of Hematology, University of Texas-Houston Medical School, Houston, Texas 77030, USA.
American Journal of Physiology. Cell Physiology
|June 13, 2001
Summary
Transient cyclooxygenase-2 (COX-2) expression does not affect cell cycle progression or apoptosis in human fibroblasts. This study found no influence of COX-2 on primary cell proliferation or programmed cell death.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Cyclooxygenase-2 (COX-2) is often expressed in cancer cells, influencing proliferation and apoptosis.
- The role of transient COX-2 induction in primary cell cycle progression and programmed cell death remains unclear.
Purpose of the Study:
- To investigate whether COX-2 regulates proliferation or apoptosis in primary human fibroblasts.
- To determine the impact of transient COX-2 expression on cell cycle dynamics.
Main Methods:
- Quantification of COX-2 mRNA, protein, and prostaglandin E2 (PGE2) in human fibroblasts.
- Assessment of cell cycle progression (G0/G1 to S phase) and apoptosis.
- Pharmacological inhibition of COX-2 activity.
- Stimulation of cells with serum, interleukin-1beta, and platelet-derived growth factor.
Main Results:
- COX-2, its mRNA, and PGE2 were undetectable in quiescent fibroblasts but expressed during serum-induced G0/G1 phase.
- COX-2 inhibition did not affect G0/G1 to S phase transition or induce apoptosis.
- Interleukin-1beta enhanced COX-2 and PGE2 levels but did not alter cell cycle progression.
- Platelet-derived growth factor initiated cell cycle entry without inducing detectable COX-2 or PGE2.
Conclusions:
- Transient COX-2 expression in primary human fibroblasts does not influence cell cycle progression.
- The study indicates that COX-2 is not a critical regulator of proliferation or apoptosis in this primary cell model.